PTC Therapeutics Inc. (PTCT)

42.97
NASDAQ : Health Technology
Prev Close 42.86
Day Low/High 42.19 / 43.69
52 Wk Low/High 27.53 / 48.99
Avg Volume 458.70K
Exchange NASDAQ
Shares Outstanding 58.95M
Market Cap 2.54B
EPS -2.80
P/E Ratio N/A
Div & Yield N.A. (N.A)
PTC Therapeutics (PTCT) Showing Signs Of Perilous Reversal Today

PTC Therapeutics (PTCT) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "perilous reversal" (up big yesterday but down big today) candidate

PTC Therapeutics Enters Oversold Territory (PTCT)

PTC Therapeutics Enters Oversold Territory (PTCT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

These 5 Health Care Stocks Are Ready for Breakout Moves: Must-See Charts

These 5 Health Care Stocks Are Ready for Breakout Moves: Must-See Charts

The technical setups in these five health care stocks are showing solid upside potential right now.

Notable Wednesday Option Activity: PTCT, FMI, ENPH

Notable Wednesday Option Activity: PTCT, FMI, ENPH

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in PTC Therapeutics Inc , where a total volume of 5,985 contracts has been traded thus far today, a contract volume which is representative of approximately 598,500 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 60.9% of PTCT's average daily trading volume over the past month, of 982,175 shares.

PTC Therapeutics (PTCT) Marked As A Barbarian At The Gate

PTC Therapeutics (PTCT) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

PTC Therapeutics (PTCT) Is Today's Perilous Reversal Stock

PTC Therapeutics (PTCT) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "perilous reversal" (up big yesterday but down big today) candidate

PTC Therapeutics (PTCT) Showing Signs Of A Dead Cat Bounce Today

PTC Therapeutics (PTCT) Showing Signs Of A Dead Cat Bounce Today

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "dead cat bounce" (down big yesterday but up big today) candidate

Before the Move: Watch BioMarin Into FDA Advisory Committee

Before the Move: Watch BioMarin Into FDA Advisory Committee

BioMarin Pharmaceutical BMRN, which develops and commercializes pharmaceuticals for serious diseases and medical conditions including Duchenne muscular dystrophy is awaiting an FDA advisory committee for its DMD drug drisapersen...

These Biotech Stocks Could Move on BioMarin's Duchenne Drug FDA Panel

These Biotech Stocks Could Move on BioMarin's Duchenne Drug FDA Panel

BioMarin will almost certainly be halted all day next Tuesday, so traders should watch Sarepta Therapeutics and PTC Therapeutics as proxies.

Strong On High Volume: PTC Therapeutics (PTCT)

Strong On High Volume: PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a strong on high relative volume candidate

PTC Therapeutics (PTCT) Stock: Weak On High Volume Today

PTC Therapeutics (PTCT) Stock: Weak On High Volume Today

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a weak on high relative volume candidate

Today's Dead Cat Bounce Stock Is PTC Therapeutics (PTCT)

Today's Dead Cat Bounce Stock Is PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "dead cat bounce" (down big yesterday but up big today) candidate

First Week Of June 2016 Options Trading For PTC Therapeutics (PTCT)

First Week Of June 2016 Options Trading For PTC Therapeutics (PTCT)

Investors in PTC Therapeutics Inc saw new options begin trading this week, for the June 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Perilous Reversal Stock: PTC Therapeutics (PTCT)

Perilous Reversal Stock: PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "perilous reversal" (up big yesterday but down big today) candidate

Today's Pre-Market Mover With Heavy Volume: PTC Therapeutics (PTCT)

Today's Pre-Market Mover With Heavy Volume: PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a pre-market mover with heavy volume candidate

Perilous Reversal Stock: PTC Therapeutics (PTCT)

Perilous Reversal Stock: PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "perilous reversal" (up big yesterday but down big today) candidate

Oversold Conditions For PTC Therapeutics (PTCT)

Oversold Conditions For PTC Therapeutics (PTCT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Short Interest In PTC Therapeutics Jumps 10.6%

Short Interest In PTC Therapeutics Jumps 10.6%

The most recent short interest data has been released by the NASDAQ for the 09/15/2015 settlement date, which shows a 533,202 share increase in total short interest for PTC Therapeutics Inc , to 5,546,134, an increase of 10.64% since 08/31/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Biotech Stock Mailbag: Rebounding From Hillary's Drug Tweet; Global Blood Weighs on Bluebird

Biotech Stock Mailbag: Rebounding From Hillary's Drug Tweet; Global Blood Weighs on Bluebird

Biotech columnist Adam Feuerstein answers readers' questions about health care.

PTC Therapeutics (PTCT) Is Weak On High Volume Today

PTC Therapeutics (PTCT) Is Weak On High Volume Today

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a weak on high relative volume candidate

Perilous Reversal Stock: PTC Therapeutics (PTCT)

Perilous Reversal Stock: PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "perilous reversal" (up big yesterday but down big today) candidate

'Mad Money' Lightning Round: Eaton Is a Buy, Buy, Buy

'Mad Money' Lightning Round: Eaton Is a Buy, Buy, Buy

Cramer prefers Dominion Resources D to Pepco Holding POM and is sticking with Energy Transfer Partners ETP.

Jim Cramer's 'Mad Money' Recap: The Fed Is Making All the Right Moves

Jim Cramer's 'Mad Money' Recap: The Fed Is Making All the Right Moves

It would have been a huge mistake to raise interest rates, especially since there's no compelling reason to do so, Cramer says.

PTC Therapeutics (PTCT) Marked As A Dead Cat Bounce Stock

PTC Therapeutics (PTCT) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "dead cat bounce" (down big yesterday but up big today) candidate

First Week of October 16th Options Trading For PTC Therapeutics (PTCT)

First Week of October 16th Options Trading For PTC Therapeutics (PTCT)

Investors in PTC Therapeutics Inc saw new options begin trading this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PTCT options chain for the new October 16th contracts and identified one put and one call contract of particular interest.

Predicting the Outcome of the BioMarin and Sarepta FDA Drug Reviews

Predicting the Outcome of the BioMarin and Sarepta FDA Drug Reviews

Approving both the BioMarin and Sarepta drugs for Duchenne muscular dystrophy is the most politically expedient decision the FDA can make.

PTC Therapeutics (PTCT) Is Strong On High Volume Today

PTC Therapeutics (PTCT) Is Strong On High Volume Today

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a strong on high relative volume candidate

‘Female Viagra’ approval seen as positive for Sarepta, BioMarin

‘Female Viagra’ approval seen as positive for Sarepta, BioMarin

The FDA’s approval of the world's first drug designed to boost a woman's sexual desire is seen as boding well for companies awaiting critical decisions by the agency.

Perilous Reversal Stock: PTC Therapeutics (PTCT)

Perilous Reversal Stock: PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a "perilous reversal" (up big yesterday but down big today) candidate

Today's Pre-Market Mover With Heavy Volume: PTC Therapeutics (PTCT)

Today's Pre-Market Mover With Heavy Volume: PTC Therapeutics (PTCT)

Trade-Ideas LLC identified PTC Therapeutics (PTCT) as a pre-market mover with heavy volume candidate

TheStreet Quant Rating: D (Sell)